Health-Related Quality of Life in Gay Men With Localized Prostate Cancer
NCT00828633 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92
Last updated 2018-01-23
Summary
RATIONALE: Gathering information about prostate cancer, treatment, and quality of life from gay men with prostate cancer may help doctors plan the best treatment.
PURPOSE: This clinical trial is collecting information about health-related quality of life from gay men with localized prostate cancer.
Conditions
Sponsors & Collaborators
-
Baylor College of Medicine
lead OTHER
Principal Investigators
-
David M. Latini, PhD · Baylor College of Medicine
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-08-31
- Primary Completion
- 2010-12-31
- Completion
- 2015-06-30
Countries
- United States
- Canada
Study Locations
More Related Trials
-
Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer
NCT02615223 ·Status: UNKNOWN ·Phase: NA
-
Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
NCT06733350 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacokinetics Pharmacodynamics and Safety of LY01022 in Patients With Prostate Cancer Compared With Zoladex® 10.8mg
NCT05856630 ·Status: UNKNOWN ·Phase: PHASE1
-
Study of How People Make Decisions About Prostate Cancer Risk
NCT07197723 ·Status: RECRUITING
-
A Study of Leuprolide to Treat Prostate Cancer
NCT00626431 ·Status: COMPLETED ·Phase: PHASE3
-
Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer
NCT02168062 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients
NCT00630799 ·Status: TERMINATED ·Phase: PHASE3
-
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
NCT01120236 ·Status: COMPLETED ·Phase: PHASE2
-
Addressing Health Literacy With a Tailored Survivorship Care Plan
NCT06674863 ·Status: RECRUITING ·Phase: NA
-
A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer
NCT03450109 ·Status: COMPLETED ·Phase: PHASE1
-
To Live Better After Prostate Cancer Treatment:
NCT05100121 ·Status: RECRUITING ·Phase: NA
-
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
NCT00052481 ·Status: COMPLETED
-
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
NCT00771017 ·Status: WITHDRAWN ·Phase: PHASE2
-
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program
NCT00035217 ·Status: COMPLETED
-
Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8
NCT02470936 ·Status: COMPLETED ·Phase: NA
-
Lycopene in Treating Patients With Metastatic Prostate Cancer
NCT00068731 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of the Prostate Cancer Foundation Screening Guidelines for Black Men on Intention to Screen in Faith-based Communities
NCT06838325 ·Status: COMPLETED ·Phase: NA
-
Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer
NCT01163084 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies
NCT04105920 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer
NCT00521781 ·Status: TERMINATED ·Phase: PHASE2
-
Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)
NCT03328091 ·Status: COMPLETED ·Phase: NA
-
Nutrition and Prostate Cancer
NCT03532308 ·Status: TERMINATED ·Phase: PHASE3
-
Vector Delivery of the IL-12 Gene in Men With Prostate Cancer
NCT00406939 ·Status: COMPLETED ·Phase: PHASE1
-
Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer
NCT00551044 ·Status: COMPLETED ·Phase: NA
-
PRostate Cancer Individual Signature Evaluation Trial in Patients Undergoing Scheduled Prostate Biopsy
NCT00966095 ·Status: UNKNOWN